Search This Website

Sunday, 29 November 2020

The first case of serious side effects of covshield vaccine in India, Rs. Sought compensation of five crores

The first case of serious side effects of Corona vaccine Covishield has been reported in India. Human trials of the Covishield vaccine have had serious side effects. He has demanded compensation of Rs five crore from the company. The 40-year-old took a human trial in Chennai. This person has sent a notice to the Serum Institute of India.

The man said in the complaint that he was having difficulty in learning new things, concentrating, making decisions and in his daily work.

Yesterday, PM Modi inspected the preparation of the
vaccine. Yesterday, Prime Minister Narendra Modi toured the vaccine and inspected the corona vaccine being developed in Ahmedabad, Hyderabad and Pune. Kovishield is being built in Pune. Modi also observed this. After Modi's inspection, Adar Poonawala, CEO of Serum Institute of India (SII), said, "We will apply for permission for emergency use of Kovishield in the next two weeks."

During his visit yesterday, PM Modi interacted with officials of the Serum Institute.
During his visit yesterday, PM Modi interacted with officials of the Serum Institute.

Formula about cove shield: Jenner Institute of Oxford Uni. And British-Swedish pharmaceutical company estrejeneka
Produced Serum Institute of India, Pune
Construction Location: Hadapsar, Pune (Maharashtra)
Status final approval stage
is named after the vaccine has become the world's biggest Serum, Serum Institute, an organization with a reputation as a manufacturer kovisilda vaccination. The vaccine formula was developed by scientists at Oxford University and the British-Swedish pharma company AstraZeneca. It is being manufactured at SII's Pune-based plant based on that formula. SII's preparations to make 100 million doses are now in the final stages.

The company will make 40 million doses
punavalae said yesterday that it will buy, how many doses the government has not yet determined, but it seems unlikely that the Health Ministry is currently working on 30 to 40 million doses by the end of July. Covishield will also benefit in reducing the mentality. This is expected to result in 0% hospitalization. The effect of the virus will be reduced by 60%. Hospitalization has been 0% in the global trial of Kovishield.

Read in Gujarati news 

The vaccine has been
tested in two ways. The final phase of the cove shield has been tried in two ways. The first had a 62% effect, while the second had over 90%. On average it is around 70%. The executive director of SII claimed that production of the vaccine has started.

From January, 5-6 crore vaccines will be made every month. The stock of 8 to 100 million doses will be ready by January. The supply will start as soon as the government approves. 

No comments: